Tivanisiran sodium ophthalmic solution ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
53Sjogren syndrome1

53. Sjogren syndrome


Clinical trials : 305 Drugs : 325 - (DrugBank : 104) / Drug target genes : 58 - Drug target pathways : 188
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04819269
(ClinicalTrials.gov)
May 25, 202124/3/2021Tivanisiran for Dry Eye in Subjects With Sjögren's SyndromeTivanisiran for Dry Eye in Subjects With Sjögren's SyndromeDry Eye Disease;Sjögren SyndromeDrug: Tivanisiran sodium ophthalmic solution;Drug: Vehicle ophthalmic solutionSylentis, S.A.NULLRecruiting18 YearsN/AAll200Phase 3United States;Spain